NCT07547020

Brief Summary

Hemodynamic instability is a common and serious condition in patients undergoing liver transplantation and is associated with increased morbidity and mortality if not promptly recognized and treated. It results from multiple interacting factors, including blood loss, changes in vascular tone, cardiac dysfunction, and complications related to the surgical procedure. Traditional monitoring strategies focus on global hemodynamic variables such as blood pressure and cardiac output. However, these parameters may not accurately reflect tissue perfusion or oxygen delivery at the microcirculatory level. As a result, patients may appear hemodynamically stable while still experiencing inadequate tissue oxygenation. This study aims to evaluate hemodynamic instability using an integrative physiological approach based on the interaction between different components of the cardiovascular system. Specifically, the study will assess four key interfaces: the relationship between the heart and the arterial system, the coherence between macrocirculation and microcirculation, the interaction between venous return and the right atrium, and the coupling between the right ventricle and the pulmonary circulation. The main objective is to identify distinct hemodynamic profiles in patients during the immediate postoperative period following liver transplantation. In addition, the study will evaluate the incidence of tissue hypoxia within the first 24 hours and its association with clinical outcomes, including 30-day evolution. This is a prospective observational study conducted in adult patients admitted to the intensive care unit after liver transplantation who develop hemodynamic instability requiring vasoactive support. During the first 24 hours, multimodal hemodynamic monitoring will be performed, including assessment of cardiac function, vascular tone, venous congestion, pulmonary circulation, and markers of tissue perfusion such as lactate levels and capillary refill time. By integrating these variables, patients will be classified into different hemodynamic profiles according to the predominant underlying mechanism. This approach aims to improve the understanding of cardiovascular dysfunction in this setting and to support more individualized and physiologically guided management strategies.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
16mo left

Started May 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress1%
May 2026Sep 2027

First Submitted

Initial submission to the registry

April 14, 2026

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 23, 2026

Completed
8 days until next milestone

Study Start

First participant enrolled

May 1, 2026

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2027

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2027

Last Updated

May 1, 2026

Status Verified

April 1, 2026

Enrollment Period

1.3 years

First QC Date

April 14, 2026

Last Update Submit

April 27, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of Tissue Hypoxia in the First 24 Hours After Liver Transplantation

    Tissue hypoxia will be defined by the presence of at least one of the following criteria: elevated blood lactate levels, prolonged capillary refill time, reduced urine output, or impaired oxygenation parameters, reflecting inadequate tissue perfusion despite hemodynamic support.

    Within the first 24 hours after ICU admission

Secondary Outcomes (5)

  • Hemodynamic Profile Classification Based on Cardiovascular Coupling

    Within the first 24 hours after ICU admission

  • Degree of Hemodynamic Coherence

    Within the first 24 hours after ICU admission

  • 30-Day Mortality

    30 days

  • Organ Dysfunction within the first 24 hours after ICU admission

    Within the first 24 hours after ICU admission

  • Duration of Mechanical Ventilation and Successful Liberation from Mechanical Ventilation

    Up to 30 days

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants will be recruited from the intensive care unit of a high-complexity tertiary care hospital where liver transplantation is routinely performed

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital de Alta Complejidad en Red El Cruce

San Juan Bautista, Buenos Aires, 1853, Argentina

Location

Related Publications (6)

  • He HW, Long Y, Liu DW, Ince C. Resuscitation incoherence and dynamic circulation-perfusion coupling in circulatory shock. Chin Med J (Engl). 2019 May 20;132(10):1218-1227. doi: 10.1097/CM9.0000000000000221.

    PMID: 30896570BACKGROUND
  • Huang L, Huang Q, Ma W, Yang H. UNDERSTANDING HEMODYNAMIC INCOHERENCE: MECHANISMS, PHENOTYPES, AND IMPLICATIONS FOR TREATMENT. Shock. 2025 Mar 1;63(3):342-350. doi: 10.1097/SHK.0000000000002507. Epub 2024 Nov 8.

    PMID: 39527481BACKGROUND
  • Agostini C, Buccianti S, Risaliti M, Fortuna L, Tirloni L, Tucci R, Bartolini I, Grazi GL. Complications in Post-Liver Transplant Patients. J Clin Med. 2023 Sep 24;12(19):6173. doi: 10.3390/jcm12196173.

    PMID: 37834818BACKGROUND
  • Newby DE, Hayes PC. Hyperdynamic circulation in liver cirrhosis: not peripheral vasodilatation but 'splanchnic steal'. QJM. 2002 Dec;95(12):827-30. doi: 10.1093/qjmed/95.12.827. No abstract available.

    PMID: 12454326BACKGROUND
  • Wang L, Bui CM, Hofer I, Gabel E, Wray C, Xia VW. Intraoperative Hypotension and 30-D Mortality After Liver Transplantation. Transplant Direct. 2022 Sep 15;8(10):e1380. doi: 10.1097/TXD.0000000000001380. eCollection 2022 Oct.

    PMID: 36204192BACKGROUND
  • Bezinover D, Mukhtar A, Wagener G, Wray C, Blasi A, Kronish K, Zerillo J, Tomescu D, Pustavoitau A, Gitman M, Singh A, Saner FH. Hemodynamic Instability During Liver Transplantation in Patients With End-stage Liver Disease: A Consensus Document from ILTS, LICAGE, and SATA. Transplantation. 2021 Oct 1;105(10):2184-2200. doi: 10.1097/TP.0000000000003642.

    PMID: 33534523BACKGROUND

MeSH Terms

Conditions

Shock

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
30 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Specialist in Intensive Care Medicine

Study Record Dates

First Submitted

April 14, 2026

First Posted

April 23, 2026

Study Start

May 1, 2026

Primary Completion (Estimated)

August 1, 2027

Study Completion (Estimated)

September 1, 2027

Last Updated

May 1, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations